+629.1%
MRNA vs CBRE
+225.6%
+403.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CBRE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.8% | -1.5% | -2.7% |
| 7D | -10.1% | -1.7% | -8.4% | -9.6% |
| 30D | +126.7% | -3.0% | +129.7% | +132.7% |
| 3M | +184.1% | +2.6% | +181.5% | +187.3% |
| 6M | +143.3% | +2.0% | +141.3% | +146.5% |
| YTD | +359.9% | -13.1% | +373.0% | +384.0% |
| 1Y | +454.2% | -13.8% | +468.0% | +484.9% |
| 3Y | +26.0% | +63.9% | -37.9% | +15.7% |
| 5Y | -70.3% | +42.3% | -112.6% | -73.0% |
| All | +629.1% | +225.6% | +403.5% | +444.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CBRE.
Daily Out/Under-Performance
Portfolio return minus CBRE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CBRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CBRE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling